Analysts' average 12-month price target for Cooper Companies is $71.
Get informed when a big investor buys or sells
+ Follow$53.91
12 analysts in the last 4 months
High: $86 | Low: $59
No recommendations in the last 4 months.
As of the most recent data, COO shows a target price of $71. Scroll down for historical charts and peer comparison views.
If Cooper Companies moved to the average analyst target of $71, shares would be roughly 31.2% higher than $53.91. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Cooper Companies's earnings trajectory.
Besides this target price page, Stockcircle has Cooper Companies's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $71) with ownership activity and broader fundamentals.
Cooper Companies's target price is $71; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.